Standigm
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
70 Nonhyeon-ro 85-gil, Villefranche-sur-...Phone Number
+82 25018118Website
www.standigm.comRevenue
$15.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Standigm
Founded in 2015, Standigm is a leading Korean Artificial Intelligence (AI) company for drug discovery. Applying its own innovative AI to the real world, Standigm currently has more than 20 preclinical pipelines across various therapeutic areas. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK for target discovery, Standigm BEST for lead selection, and Standigm Insight for drug repurposing. The company is headquartered in Seoul, South Korea.Explore more
Standigm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Standigm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Standigm has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Standigm
Website visits: Recent activity has been detected on your website
Standigm, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Standigm had a recent Job posting/layoffs
Product Launch: Get notified when Standigm launches new products
Check if Standigm has recently received funding, and reach out quickly before it becomes old news!
Check out if Standigm is spiking on competitors!
Earning: See what the market has to say on Standigm recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Standigm is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Standigm is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Standigm.
Standigm financials insights
Gather financial insights about Standigm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$11.5M
2021
Other Financing Round
$44.5M
Standigm Tech Stack
A closer look at the technologies used by Standigm
Most Recent Scoops
Event
Events
New Hire
Executive Move
New Hire
Executive Move
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Facilities Relocation / Expansion
Standigm News & Media
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week
SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using artificial intelligence (AI) technology for drug discovery and development launched, the "Green Ribbon Campaign," event to support the upcoming Mitochondrial Disease Awareness Week scheduled for September 18th to 24th. At this event, the Standigm community handcrafted green ribbons, symbolizing hope for those affected by mitochondrial disease. This initiative aims to raise awareness and extend StaStandigm and Nashville Biosciences join to revolutionize early drug discovery
Companies will identify novel therapeutic targets using Standigm's explainable AI and Nashville Biosciences' datasets SEOUL, South Korea, Aug. 10, 2023 /PRNewswire/ -- Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, today announced...Standigm announces Younsung Choo as chief executive officer
Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmaceuticals and project management SEOUL, South Korea, April 13, 2023 /PRNewswire/ -- Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that Younsung Choo has been appointed Chief Executive Officer (CEO). As the new CEO of Standigm, Choo will focus primarily on company strategy, planning, R&D and business development. Choo is no stranger toStandigm and Institut Pasteur Korea Identify Drug Candidates for Resistant Tuberculosis Thanks to Right Foundation Grant
Research achievements enabled by a combination of advanced AI platforms, research capabilities, and drug discovery technologies SEOUL, South Korea, April 5, 2023 /PRNewswire/ -- Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB). The two organizations conducted a technolog
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Standigm
Sign Up For FreeTo access detailed company insights
Founded in 2015, Standigm is a leading Korean Artificial Intelligence (AI) company for drug discovery. Applying its own innovative AI to the real world, Standigm currently has more than 20 preclinical pipelines across various therapeutic areas. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of mo... Read More
